| Name | Kif15-IN-1 |
|---|---|
| Synonyms |
5-Thiazolecarboxylic acid, 2-[[(2S)-2-(1,4-dihydro-2,4-dioxo-3(2H)-quinazolinyl)-3-methyl-1-oxobutyl]amino]-4-methyl-, ethyl ester
Ethyl 2-{[(2S)-2-(2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)-3-methylbutanoyl]amino}-4-methyl-1,3-thiazole-5-carboxylate |
| Description | Kif15-IN-1 is an inhibitor of the mitotic kinesin Kif15, and is used for the research of cellular proliferative diseases. |
|---|---|
| Related Catalog | |
| Target |
KIF15 |
| In Vitro | Kif15-IN-1 (Compound 10) is an inhibitor of the mitotic kinesin Hs Kif15, with the potential activities against cellular proliferative diseases such as cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation[1]. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Molecular Formula | C20H22N4O5S |
| Molecular Weight | 430.478 |
| Exact Mass | 430.131104 |
| LogP | 3.73 |
| Index of Refraction | 1.619 |
| Storage condition | 2-8℃ |